USDTL Research
Neonatal Cord Tox Panel and Maternal Perinatal Fentanyl Exposure: A Retrospective Chart Review
First published: September 2021 https://doi.org/10.4236/ajac.2021.129020
Abstract
Objective: The specific aim of this study was to determine if the currently available cutoff for fentanyl in umbilical cord (UC) was appropriate to distinguish illicit fentanyl exposure from therapeutic in-hospital administration of fentanyl.
Study Design: Medical record review was conducted for perinatal administration of fentanyl and the detection of fentanyl in the corresponding routine UC toxicology. Specimens were initially tested with immunoassay followed by mass spectrometry (n = 62).
Result: Excluding a single specimen that was confirmed positive, specimens were below the assays’ limit of quantification. The immunoassay’s mean b/b0 for the cases that received and did not receive fentanyl prior to delivery was 91.3% ± 10.6% and 98.2% ± 6.5%, respectively (p = 0.003).
Conclusion: We demonstrated that UC is a suitable specimen type for the detection of fentanyl and that the cutoff selected adequately identifies illicit fentanyl use while not flagging cases where fentanyl was administered by the hospital prior to birth.
Read Full Article
Published by: United States Drug Testing Laboratories on 22-Apr-2022
https://www.usdtl.com/media/articles/neonatal-cord-tox-panel-and-maternal-perinatal-fentanyl-exposure-a-retrospective-chart-review
Contact USDTL
1.800.235.2367
Newsletters, Posters, and Catalogs
Our print materials will keep you up to date on the latest news in drug and alcohol testing.
Request Your Collection Supplies
For your convenience, USDTL provides test collection supplies at no additional charge.